Dental Implant Supported Restorations Improve Quality of Life in Osteoporotic Women

Table 1

Participant demographics. Characteristics of the study population (237 participants).

Factor	Implant	FPD	RPD	No restoration = 66
Age	62 ± 8.3	63 ± 7.4	59 ± 8.1	61 ± 10.9
Race (%)
White	31 (48)	27 (45)	26 (55)	32 (49)
Black	28 (43)	30 (50)	19 (40)	26 (39)
Hispanic	5 (8)	3 (5)	2 (4)	8 (12)
BMI
<19	22	16	10	14
20–29	38	35	25	38
>30	4	9	12	14
Tobacco use
Never	26	18	10	28
Former	34	30	18	25
Current	4	12	19	13
Hormone replacement
Never	12	13	16	32
Former	39	35	26	22
Current	15	12	5	12
Bone sparing Medications
Oral bisphosphonate (in the last 5 years)	35	32	31	36
Alendronate	24	22	18	20
Risedronate	5	6	10	12
Ibandronate	6	4	3	4
IV bisphosphonate (in the last 5 years)	12	15	10	14
Selective estrogen receptor modulators (SERM)	3	0	2	5
RANKL inhibitor	3	5	1	1
None	11	8	3	10